Root Financial Partners LLC purchased a new stake in shares of CVS Health Co. (NYSE:CVS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,534 shares of the pharmacy operator's stock, valued at approximately $248,000.
A number of other large investors have also added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. bought a new stake in CVS Health in the 3rd quarter worth approximately $25,000. Ridgewood Investments LLC grew its position in CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC purchased a new position in shares of CVS Health during the 4th quarter worth $28,000. Livelsberger Financial Advisory purchased a new position in shares of CVS Health during the 3rd quarter worth $31,000. Finally, Legacy Investment Solutions LLC purchased a new position in shares of CVS Health during the 3rd quarter worth $31,000. Institutional investors own 80.66% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. Royal Bank of Canada dropped their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research note on Friday, November 15th. Evercore ISI lifted their price target on shares of CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a research note on Monday, January 27th. Truist Financial lifted their price target on shares of CVS Health from $60.00 to $76.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. TD Cowen lifted their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday, November 25th. Finally, Mizuho lowered their target price on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a research note on Thursday, October 24th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $70.00.
Read Our Latest Analysis on CVS
CVS Health Price Performance
Shares of CVS Health stock traded down $0.36 during trading hours on Tuesday, reaching $65.47. The company's stock had a trading volume of 10,103,286 shares, compared to its average volume of 13,252,714. The firm has a 50 day moving average price of $51.30 and a 200-day moving average price of $56.03. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The stock has a market cap of $82.39 billion, a P/E ratio of 16.62, a P/E/G ratio of 0.60 and a beta of 0.61.
CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. On average, analysts predict that CVS Health Co. will post 5.14 EPS for the current year.
CVS Health Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.06%. CVS Health's payout ratio is 67.51%.
About CVS Health
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
